# \[e-drug\] Re: Pharmaceutical Innovation in a Global Economy **URL:** \ **Category:** e-drug\ **Created:** [June 13, 2002, 6:28am UTC](https://talk.edrugplus.org/t/e-drug-re-pharmaceutical-innovation-in-a-global-economy/14523 "2002-06-13T06:28:17Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![nlb1](https://avatars.discourse-cdn.com/v4/letter/n/edb3f5/32.png) [@nlb1](https://talk.edrugplus.org/u/nlb1)\ **Post date:** [June 13, 2002, 6:28am UTC](https://talk.edrugplus.org/t/e-drug-re-pharmaceutical-innovation-in-a-global-economy/14523/1 "2002-06-13T06:28:17Z")
E-drug: Re: Pharmaceutical Innovation in a Global Economy ------------------------------------------------------------------------- I had sent an earlier message about this conference before their website was operational. Apologies to those who could not get the information at that time. The agenda is now complete and their website is accessible so, anyone interested in this meeting should go to: [http://hc.wharton.upenn.edu/impactconference/](http://hc.wharton.upenn.edu/impactconference/) or contact Eric Bianchi at ebianchi@wharton.upenn.edu Nancy Blum, M.P.H., M.A. Program Director, Global Assistance Initiatives U.S.Pharmacopeia 12601 Twinbrook Parkway Rockville, MD 20852 (301) 816-8161 (301) 816-8374 FAX [Previous message posted 3 May 2002: Health Care Systems Department to Sponsor Wharton Impact Conference, October 4-5, 2002, 351 Steinberg-Dietrich Hall, Penn Campus. Professor Patricia Danzon is the principal organizer of a Wharton Impact Conference on Pharmaceutical Innovation in the Global Economy. The objective of the conference is to encourage dialogue and research on the important topic of increasing the availability and affordability of drugs for less developed countries (LDC's), while preserving patents and incentives for innovation. The conference is not designed to broker political compromise between various interest groups. Rather, the focus is on research qusestions and issues where analytic skills at Wharton, our understanding of the private sector and of lessons from other industries can contribute to sound strategy and public policy. The three main sub-themes to be addressed by the conference are: 1) Pricing and international price differentials for drugs with first world markets; 2) Improving incentives to develop new medicines for LDC diseases; 3) Patents, tax credits and other policy/implementation issues. To download Professor Danzon's Conference-related paper "Differential Pricing for Pharmaceuticals: Reconciling Access, R&D, and Patents" go to [http://hc.wharton.upenn.edu/danzon/index.htm](http://hc.wharton.upenn.edu/danzon/index.htm), then click on "Publications", then click on "Articles and Chapters in Books". All alumni and other interested professionals are invited to attend the Conference. For registration and hotel information, email Eric Bianchi at ebianchi@wharton.upenn.edu] -- To send a message to E-Drug, write to: e-drug@usa.healthnet.org To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org in the body of the message type: subscribe e-drug OR unsubscribe e-drug To contact a person, send a message to: e-drug-help@usa.healthnet.org Information and archives: [http://www.healthnet.org/programs/edrug.html](http://www.healthnet.org/programs/edrug.html)